A PHASE I/II TRIAL OF IBRUTINIB, INTRATUMORAL CPG AND LOCAL RADIATION IN PATIENTS WITH LOW‐GRADE B‐CELL LYMPHOMA: INTERIM CLINICAL AND CORRELATIVE RESULTS

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hematological oncology 2019-06, Vol.37 (S2), p.122-123
Hauptverfasser:	Shree, T., Khodadoust, M.S., Czerwinski, D., Frank, M.J., Hong, W.X., Greenstein, R., Long, S., Martin, B., Levy, R.
Format:	Artikel
Sprache:	eng
Schlagworte:	B-cell lymphoma Lymphocytes B Lymphoma Radiation Targeted cancer therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	123
container_issue	S2
container_start_page	122
container_title	Hematological oncology
container_volume	37
creator	Shree, T. Khodadoust, M.S. Czerwinski, D. Frank, M.J. Hong, W.X. Greenstein, R. Long, S. Martin, B. Levy, R.
description
doi_str_mv	10.1002/hon.82_2629
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2242709131</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2242709131</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1089-ff6751b5926eb52317251f662103efab9cf6a4445c1f10e9d82b132ac5afb4ec3</originalsourceid><addsrcrecordid>eNp9kUtOwzAQhi0EEuWx4gKWWEJa23maXRrcxpKbVK4DYmUlIRYgoCWhQt1xBE7A4TgJjlq2rGZG8803ix-AM4yGGCEyeli-DiOiSUDoHhhgRKmDUUD3wQCRMHIQcckhOOq6J4TsDkUD8B3DeRovGOQjzqGSPBYwn0A-loXiGR9fQp4pGatilku7SuZTGGfXUOSJnWR8zWPF88xCcG47lqkFvOUqtcDtz-fX1BIMjm2XMCGguJvN03wWX_VSJvkMJsI-6VW9NMmlZMJqbhiUbFEItTgBB6Z87prTXT0GxYSpJHVEPu3vnBqjiDrGBKGPK5-SoKl84uKQ-NgEAcHIbUxZ0doEped5fo0NRg29j0iFXVLWfmkqr6ndY3C-9a7a5du66d7103LdvtqXmhCPhIhiF1vqYkvV7bLr2sboVfv4UrYbjZHuA9A2AL0LwNLulv54fG42_6E6zbO_q19q8n3m</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2242709131</pqid></control><display><type>article</type><title>A PHASE I/II TRIAL OF IBRUTINIB, INTRATUMORAL CPG AND LOCAL RADIATION IN PATIENTS WITH LOW‐GRADE B‐CELL LYMPHOMA: INTERIM CLINICAL AND CORRELATIVE RESULTS</title><source>Wiley Journals</source><creator>Shree, T. ; Khodadoust, M.S. ; Czerwinski, D. ; Frank, M.J. ; Hong, W.X. ; Greenstein, R. ; Long, S. ; Martin, B. ; Levy, R.</creator><creatorcontrib>Shree, T. ; Khodadoust, M.S. ; Czerwinski, D. ; Frank, M.J. ; Hong, W.X. ; Greenstein, R. ; Long, S. ; Martin, B. ; Levy, R.</creatorcontrib><identifier>ISSN: 0278-0232</identifier><identifier>EISSN: 1099-1069</identifier><identifier>DOI: 10.1002/hon.82_2629</identifier><language>eng</language><publisher>Chichester: Wiley Subscription Services, Inc</publisher><subject>B-cell lymphoma ; Lymphocytes B ; Lymphoma ; Radiation ; Targeted cancer therapy</subject><ispartof>Hematological oncology, 2019-06, Vol.37 (S2), p.122-123</ispartof><rights>2019 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhon.82_2629$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhon.82_2629$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids></links><search><creatorcontrib>Shree, T.</creatorcontrib><creatorcontrib>Khodadoust, M.S.</creatorcontrib><creatorcontrib>Czerwinski, D.</creatorcontrib><creatorcontrib>Frank, M.J.</creatorcontrib><creatorcontrib>Hong, W.X.</creatorcontrib><creatorcontrib>Greenstein, R.</creatorcontrib><creatorcontrib>Long, S.</creatorcontrib><creatorcontrib>Martin, B.</creatorcontrib><creatorcontrib>Levy, R.</creatorcontrib><title>A PHASE I/II TRIAL OF IBRUTINIB, INTRATUMORAL CPG AND LOCAL RADIATION IN PATIENTS WITH LOW‐GRADE B‐CELL LYMPHOMA: INTERIM CLINICAL AND CORRELATIVE RESULTS</title><title>Hematological oncology</title><subject>B-cell lymphoma</subject><subject>Lymphocytes B</subject><subject>Lymphoma</subject><subject>Radiation</subject><subject>Targeted cancer therapy</subject><issn>0278-0232</issn><issn>1099-1069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kUtOwzAQhi0EEuWx4gKWWEJa23maXRrcxpKbVK4DYmUlIRYgoCWhQt1xBE7A4TgJjlq2rGZG8803ix-AM4yGGCEyeli-DiOiSUDoHhhgRKmDUUD3wQCRMHIQcckhOOq6J4TsDkUD8B3DeRovGOQjzqGSPBYwn0A-loXiGR9fQp4pGatilku7SuZTGGfXUOSJnWR8zWPF88xCcG47lqkFvOUqtcDtz-fX1BIMjm2XMCGguJvN03wWX_VSJvkMJsI-6VW9NMmlZMJqbhiUbFEItTgBB6Z87prTXT0GxYSpJHVEPu3vnBqjiDrGBKGPK5-SoKl84uKQ-NgEAcHIbUxZ0doEped5fo0NRg29j0iFXVLWfmkqr6ndY3C-9a7a5du66d7103LdvtqXmhCPhIhiF1vqYkvV7bLr2sboVfv4UrYbjZHuA9A2AL0LwNLulv54fG42_6E6zbO_q19q8n3m</recordid><startdate>201906</startdate><enddate>201906</enddate><creator>Shree, T.</creator><creator>Khodadoust, M.S.</creator><creator>Czerwinski, D.</creator><creator>Frank, M.J.</creator><creator>Hong, W.X.</creator><creator>Greenstein, R.</creator><creator>Long, S.</creator><creator>Martin, B.</creator><creator>Levy, R.</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>201906</creationdate><title>A PHASE I/II TRIAL OF IBRUTINIB, INTRATUMORAL CPG AND LOCAL RADIATION IN PATIENTS WITH LOW‐GRADE B‐CELL LYMPHOMA: INTERIM CLINICAL AND CORRELATIVE RESULTS</title><author>Shree, T. ; Khodadoust, M.S. ; Czerwinski, D. ; Frank, M.J. ; Hong, W.X. ; Greenstein, R. ; Long, S. ; Martin, B. ; Levy, R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1089-ff6751b5926eb52317251f662103efab9cf6a4445c1f10e9d82b132ac5afb4ec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>B-cell lymphoma</topic><topic>Lymphocytes B</topic><topic>Lymphoma</topic><topic>Radiation</topic><topic>Targeted cancer therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shree, T.</creatorcontrib><creatorcontrib>Khodadoust, M.S.</creatorcontrib><creatorcontrib>Czerwinski, D.</creatorcontrib><creatorcontrib>Frank, M.J.</creatorcontrib><creatorcontrib>Hong, W.X.</creatorcontrib><creatorcontrib>Greenstein, R.</creatorcontrib><creatorcontrib>Long, S.</creatorcontrib><creatorcontrib>Martin, B.</creatorcontrib><creatorcontrib>Levy, R.</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Hematological oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shree, T.</au><au>Khodadoust, M.S.</au><au>Czerwinski, D.</au><au>Frank, M.J.</au><au>Hong, W.X.</au><au>Greenstein, R.</au><au>Long, S.</au><au>Martin, B.</au><au>Levy, R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A PHASE I/II TRIAL OF IBRUTINIB, INTRATUMORAL CPG AND LOCAL RADIATION IN PATIENTS WITH LOW‐GRADE B‐CELL LYMPHOMA: INTERIM CLINICAL AND CORRELATIVE RESULTS</atitle><jtitle>Hematological oncology</jtitle><date>2019-06</date><risdate>2019</risdate><volume>37</volume><issue>S2</issue><spage>122</spage><epage>123</epage><pages>122-123</pages><issn>0278-0232</issn><eissn>1099-1069</eissn><cop>Chichester</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/hon.82_2629</doi><tpages>2</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0278-0232
ispartof	Hematological oncology, 2019-06, Vol.37 (S2), p.122-123
issn	0278-0232 1099-1069
language	eng
recordid	cdi_proquest_journals_2242709131
source	Wiley Journals
subjects	B-cell lymphoma Lymphocytes B Lymphoma Radiation Targeted cancer therapy
title	A PHASE I/II TRIAL OF IBRUTINIB, INTRATUMORAL CPG AND LOCAL RADIATION IN PATIENTS WITH LOW‐GRADE B‐CELL LYMPHOMA: INTERIM CLINICAL AND CORRELATIVE RESULTS
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T09%3A03%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20PHASE%20I/II%20TRIAL%20OF%20IBRUTINIB,%20INTRATUMORAL%20CPG%20AND%20LOCAL%20RADIATION%20IN%20PATIENTS%20WITH%20LOW%E2%80%90GRADE%20B%E2%80%90CELL%20LYMPHOMA:%20INTERIM%20CLINICAL%20AND%20CORRELATIVE%20RESULTS&rft.jtitle=Hematological%20oncology&rft.au=Shree,%20T.&rft.date=2019-06&rft.volume=37&rft.issue=S2&rft.spage=122&rft.epage=123&rft.pages=122-123&rft.issn=0278-0232&rft.eissn=1099-1069&rft_id=info:doi/10.1002/hon.82_2629&rft_dat=%3Cproquest_cross%3E2242709131%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2242709131&rft_id=info:pmid/&rfr_iscdi=true